 |
Hon. John Hill BA, Dip Ed, LLB, FAICD
Independent Chair, Private Healthcare Australia
John is former SA Cabinet Minister [2002 - 2013], including more than seven years as Minister for Health [2005 - 2013]. Since retiring from politics John has served as a director of various organisations. Current roles include: Deputy Chancellor, University of South Australia; Chair, Goyder Institute for Water Research; Deputy Chair, ACH Group and Director, Bellberry Limited.
|
 |
Leanne Wells is the Chief Executive Officer of the Consumers Health Forum of Australia. She is a health advocate and service executive with over thirty years’ experience in health and social policy, program and service development. Leanne has held executive positions within federal government and in national and state non-government organisations. Leanne is Board Director of Coordinare South East New South Wales’ Primary Health Network, the Ozhelp Foundation, PainAustralia and the Australian Pharmacy Council. She is the Independent Chair of Coordinare’s Community Advisory Committee. She has several advisory appointments including the Commonwealth’s Primary Health Care Advisory Group, NSW Agency for Clinical Innovation’s International Expert Advisory Committee and the Primary Care Committee of the Australian Commission for Safety and Quality in Healthcare’s Board. Leanne has tertiary qualifications in communications and business. She is a member of both the Australian Institute of Company Directors and the Australian Institute of Management. |
 |
Elly Lynch is Clinical Project Manager at Melbourne Genomics. Elly Lynch is seconded to the Melbourne Genomics Project Team from the Victorian Clinical Genetics Service. Elly has more than 16 years' experience as a Genetic Counsellor. She holds a Bachelor of Science and Graduate Diploma in Genetic Counselling from the University of Melbourne and is a Fellow of the Human Genetics Society of Australasia and member of the Board of Censors for Genetic Counselling. Before joining VCGS, Elly worked at Austin Health, The Royal Melbourne Hospital and The Royal Marsden Hospital.
|
 |
Chris White is a former Ethics Lecturer who spent most of his full-time career as a consulting actuary and in consulting firm management with Towers Perrin (now Willis Towers Watson) in Australia and Europe. After retiring early in 1999 he studied Christian Ethics (MA, King’s College London), and the relationship between Christian Ethics and Economics (PhD, ANU). He has taught ethics in various contexts (for the actuarial profession, in a theological college, and in Macquarie University’s finance masters program). He has been a member of various boards and committees in both commercial and not-for-profit sectors, and is currently independent board chair of an industry superannuation fund.
|
 |
Adam Dunn is an Associate Professor in the Centre for Health Informatics, Macquarie University. He leads two research streams in: clinical research informatics, using large datasets of clinical trial registrations to improve systematic reviews and drug safety research; and public health informatics, using large datasets from news and social media to mitigate the impact of misinformation on health attitudes and behaviours.
|
 |
Dr Jananie William is a Senior Lecturer in Actuarial Studies at the Australian National University and Advisor to The Social Outcomes Lab. She has over 15 years of experience in both traditional and non-traditional areas of actuarial practice through industry and academic roles. Her research is focussed on the application of actuarial techniques in women’s health. Her current projects include costing studies in maternal health and the lifetime health system costs of women who experience intimate partner violence. Prior to joining the university, Jananie worked in actuarial roles in the general insurance and investment advisory industry in Australia and the UK.
|
 |
Natalie Kelly has 15 years’ experience in senior roles across the healthcare, finance and Government sectors and is currently Divisional General Manager, Provider Commercials and Operations at Medibank. Natalie’s role is to develop and deliver on the strategy for Medibank’s $A5b+ expenditure on healthcare services and align to Medibank’s business strategy and growth targets. This involves managing an extensive provider network of private and public hospitals, medical specialists and ancillary providers with contract management, fraud and prevention, strategy and insight development and operational activities. Natalie manages a diverse team of 150 people including analysts and data scientists, strategy analysts, contract managers as well as investigators.
Prior to joining Medibank, Natalie was the Senior Healthcare Analyst in the Institutional Equities Group at the Commonwealth Bank of Australia providing investment advice on a number of healthcare companies to institutional investors. She was also a Senior Project Officer in the Mergers and Asset Sales division of the Australian Competition and Consumer Commission assessing mergers and acquisitions. Natalie has a Masters Degree in Commerce (Economics) from The University of Melbourne and is also a graduate of the Australian Institute of Company Directors and the University of Oxford Advanced Management and Leadership Programme. |
 |
Pia Clinton-Tarestad is a Partner in Monitor Deloitte, specialising in health system redesign and improvement. This has included leading national strategy & policy projects, working with hospitals to redesign their clinical services and estate, and working with whole health systems to improve patient flow and service effectiveness.
Pia is the Deloitte’s lead in Australia for Smart Health Solutions and has successfully launched several digital innovations into the Australian market, such as using machine learning to predict and prevent adverse outcomes.
Pia spent 13 years in the national health system in England in hospital management, healthcare planning & purchasing. Her last role prior to joining Deloitte was as Head of Specialised Commissioning for England, with responsibility for the planning, budgeting and contracting of £15bn of NHS spend in rare and complex diseases. She holds a Masters in health economics and maintains a keen interest in the ethical and technical challenges associated with resource allocation in the public sector.
|
 |
Tony Coleman BA MBA Hon DBus (Macq) FIAA CERA FAICD
Tony has a history of delivering successful outcomes as a Chairman, director, adviser and senior executive with a range of leading Australian and international organisations operating in private, public and non-for-profit sector environments, including both large well established organisations and start-ups.
His current roles relevant to the FOHS are both at Macquarie University where he is:
- Chairman, Industry Advisory Committee for the Centre for the Health Economy; and
- Member, Human & Medical Research Ethics Committee.
In recent years, Tony has also served as a Director of Max BUPA Health Insurance Limited (in India) which was a start-up entity when he joined the board. By the time Tony retired from the board after the first six years of the company’s life, Max Bupa had grown strongly with over 1,500 staff and more than 1,000,000 policyholders.
Earlier in his career, Tony was Chief Risk Officer and Group Actuary of Insurance Australia Group (IAG) reporting direct to the CEO for eight years and prior to joining IAG, Tony was a partner of PricewaterhouseCoopers (PwC) for 15 years.
Tony was the President of the Actuaries Institute (IAAust) in 2001 and is also a former winner of the IAAust’s 'Actuary of the Year' award. Macquarie University awarded Tony an Honorary Doctor of Business Degree in 2011 in recognition of his contributions to risk management, institutional investment and climate change.
|
 |
Dr Henry Cutler is the inaugural Director of Macquarie University’s Centre for the Health Economy (MUCHE). He leads several research teams undertaking health economic analysis funded by competitive academic grants, along with government and non-government organisations. His work focuses on health statistics and econometrics, health insurance, markets in healthcare, economic evaluation, health and the economy, demand for healthcare and supply of health care services. He is an affiliated researcher within Macquarie University’s Centre for Emotional Health and Centre for Implementation of Hearing Research, NHMRC Centre for Health System Sustainability, NHMRC Centre for Research Excellence in Digital Health, NHMRC Centre for Research Excellence in Suicide Prevention and Digital Health Cooperative Research Centre. He has undertaken close to 100 research projects and contributes regularly to media including the ABC, AFR, The Australian and SMH. |
 |
Sue Williams has more than 25 years’ experience in the healthcare industry at senior management level in both the public and private sectors. Sue started her career in health care as an 18 year old trainee nurse at the Royal Melbourne Hospital. After initial ward training, she gained her Critical care certificate. With a clear intention to take on leadership positions in Healthcare, she enrolled at Monash undertaking a Bachelor of Business Management, where she was the top graduating student. Realizing there was still much to learn, Sue completed a Master of Business Administration at Monash in 1999. More recently, Sue has completed the Advanced Management Program at Harvard University and the Australian Institute of Company Directors course.
Sue has had a diverse career, from trainee nurse, through to Director of Nursing at the Royal Melbourne Hospital, Chief Operating Officer of 44 hospitals at Healthscope, to network Chief Executive Officer at Peninsula Health. She is currently Chief of Health Operations at Cabrini Health and holds a number of Board positions.
Despite her busy career, Sue remains grounded by her family - husband Trevor, a physician and Monash Alumni, son Ben and daughter Stephanie, soon to be another Monash Alumni.
|
 |
In 2015, Stefan Harrer founded the Brain-Inspired Computing Research program of IBM Research – Australia and now leads it as its Manager. His team spearheads an effort to develop AI-based technology for managing and treating epilepsy. Since joining IBM Research in 2008, Stefan has worked in the fields of biotechnology, nanotechnology and healthcare analytics at IBM Albany Nanotech, and the IBM T.J. Watson Research Center in New York as well as at IBM Research Australia. He has authored and co-authored over 40 technical publications and holds over 50 issued and over 60 pending patents. Stefan has been named IBM Master Inventor in 2017 and was elected into the IBM Academy of Technology in 2018. He holds an Adjunct Professor position in the School of Engineering and Information Science at the University of Technology Sydney. As a Member of the New York Academy of Sciences and Senior Member of the IEEE he is part of the IEEE Computer Society Steering Committee and an Associate Editor of the IEEE Transactions on Nanobioscience. |